US 10421765
Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase
granted A61PA61P35/00
Quick answer
US patent 10421765 (Tetrahydropyrido[4,3-d]pyrimidine inhibitors of ATR kinase) held by The Board of Regents of the University of Texas System expires Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Sep 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61P, A61P35/00